drugset / Trial / NCT00192764
High Dose CHOP in Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study hypothesis is that intensification of CHOP by dose escalation of the most active drugs in the combination will improve treatment outcome. Patients with diffuse large-cell lymphoma are treated by high cyclophosphamide containing CHOP. The planned dose is 3000 mg/m2 which is 4 times the atandard one. Only 4 cycles are given.
Timeline
- Start
- 1996-12
- Primary completion
- —
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 3000 mg/m2 | — |